EXTRAVASATION OF PACLITAXEL (TAXOL(R))

被引：5
|
作者：
RAYMOND, E
CARTIER, S
CANUEL, C
LOUVET, C
DEMUYNCK, B
DEBRAY, M
VARETTE, C
BAUX, S
MIMOUN, M
DEGRAMONT, A
KRULIK, M
机构：
[1] Service de médecine interne-oncologie, hôpital Saint-Antoine, 75012 Paris, 184, rue du Faubourg-Saint-Antoine
[2] Service de chirurgie plastique, reconstructrice et esthétique, hôpital Rothschild, 75012 Paris, 33, boulevard de Picpus
来源：
REVUE DE MEDECINE INTERNE | 1995年 / 16卷 / 02期
关键词：
PACLITAXEL; LOCAL TOXICITY; EXTRAVASATION;
D O I：
10.1016/0248-8663(96)80679-5
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Paclitaxel is a new antimitotic derived from yew-tree, used for the treatment of ovarian and breast cancers. The local toxicity of paclitaxel is still poorly known. We report one of the first observations of accidental subcutaneous extravasation of paclitaxel. Local epidermic necrosis was observed and evolution was good with local treatment only. Treatments of such extravasation are discussed.
引用
收藏
页码：141 / 142
页数：2
相关论文
共 50 条
  • [1] Extravasation of paclitaxel (TAXOL®) -: Clinical course
    Riedel, U
    Serke, M
    Schönfeld, N
    Loddenkemper, R
    [J]. ONKOLOGIE, 1999, 22 (04): : 318 - 320
  • [2] Paclitaxel (Taxol(R)) for the treatment of lymphoma
    Younes, A
    Ayoub, JP
    Sarris, A
    North, L
    Pate, O
    McLaughlin, P
    Rodriguez, MA
    Romaguera, J
    Hagemeister, F
    Bachier, C
    Preti, A
    Cabanillas, F
    [J]. ANNALS OF ONCOLOGY, 1997, 8 : 129 - 131
  • [3] THE TAXOIDS - PACLITAXEL (TAXOL(R)) AND DOCETAXEL (TAXOTERE(R))
    PAZDUR, R
    KUDELKA, AP
    KAVANAGH, JJ
    COHEN, PR
    RABER, MN
    [J]. CANCER TREATMENT REVIEWS, 1993, 19 (04) : 351 - 386
  • [4] CLINICAL TOXICITIES ENCOUNTERED WITH PACLITAXEL (TAXOL(R))
    ROWINSKY, EK
    EISENHAUER, EA
    CHAUDHRY, V
    ARBUCK, SG
    DONEHOWER, RC
    [J]. SEMINARS IN ONCOLOGY, 1993, 20 (04) : 1 - 15
  • [5] CYCLOHEXIMIDE INHIBITS THE CYTOTOXICITY OF PACLITAXEL (TAXOL(R))
    LIEBMANN, J
    COOK, JA
    TEAGUE, D
    FISHER, J
    MITCHELL, JB
    [J]. ANTI-CANCER DRUGS, 1994, 5 (03) : 287 - 292
  • [6] NURSING CONSIDERATIONS IN PACLITAXEL (TAXOL(R)) ADMINISTRATION
    LUBEJKO, BG
    SARTORIUS, SE
    [J]. SEMINARS IN ONCOLOGY, 1993, 20 (04) : 26 - 30
  • [7] Paclitaxel (Taxol(R))-associated junctional tachycardia
    Faivre, S
    Goldwasser, F
    Soulie, P
    Misset, JL
    [J]. ANTI-CANCER DRUGS, 1997, 8 (07) : 714 - 716
  • [8] THE CLINICAL-PHARMACOLOGY OF PACLITAXEL (TAXOL(R))
    ROWINSKY, EK
    DONEHOWER, RC
    [J]. SEMINARS IN ONCOLOGY, 1993, 20 (04) : 16 - 25
  • [9] PACLITAXEL (TAXOL(R)) THERAPY IN OVARIAN-CARCINOMA
    CALDAS, C
    MCGUIRE, WP
    [J]. SEMINARS IN ONCOLOGY, 1993, 20 (04) : 50 - 55
  • [10] PACLITAXEL (TAXOL)
    KOHLER, DR
    GOLDSPIEL, BR
    [J]. PHARMACOTHERAPY, 1994, 14 (01): : 3 - 34
12345